Ebola-Filovirus

The Ebola virus disease, commonly known as Ebola, is a viral infection that primarily affects animals such as fruit bats and primates (including humans). The virus is highly contagious and can spread rapidly through direct contact with bodily fluids of infected individuals.

Symptoms of Ebola include fever, headache, joint and muscle aches, weakness, diarrhea, vomiting, stomach pain, and unexplained bleeding or bruising. The disease has a high fatality rate, and there is currently no specific treatment available for Ebola.

The 2014-2016 Ebola epidemic in West Africa was the largest outbreak of the disease in history, causing over 28,600 infections and 11,325 deaths. The outbreak highlighted the need for better preparedness and response mechanisms for infectious disease outbreaks globally.

There have been sporadic outbreaks of Ebola in various parts of Africa since its discovery in 1976. However, there have also been strides made in research and development of potential treatments and vaccines for Ebola, including the recently approved vaccine Ervebo.

Prevention of Ebola involves practicing good hygiene, avoiding contact with infected individuals and animals, and following strict infection control guidelines in healthcare settings. While Ebola remains a serious public health concern, with ongoing efforts in research and public health preparedness, there is hope for better management and prevention of future outbreaks.